MISSD Expands Akathisia Awareness and Suicide Prevention at National Conferences

Akathisia is a medication-induced disorder that can precipitate self harm, violence, and suicide.

CHICAGO, IL, UNITED STATES, March 27, 2025 /EINPresswire.com/ -- The Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin (MISSD) recently provided vital akathisia education at two national conferences: the Learning Disabilities Association of America (LDA) Annual Conference in Orlando and the Psychotherapy Networker Symposium in Washington, D.C. Attendees gained valuable insights into how certain medications can trigger psychiatric symptoms and dangerous, out-of-character behavior.

"Many people, including children, are prescribed medications associated with akathisia and related serious risks, yet key stakeholders are unaware of the potential dangers and warning signs," said Wendy Dolin, MISSD Founder. Akathisia is a medication-induced disorder that can cause intense restlessness, self-harm, violence, and suicide.

MISSD's presentation was well-received by professionals attending the conferences. "Wendy Dolin delivered eye-opening education on akathisia—a medication-induced disorder that can trigger suicidality unrelated to underlying conditions. The work of MISSD fills a critical knowledge gap in our field, reminding clinicians to remain vigilant about medication effects that clients might not recognize," said Vanessa Lewis, a licensed professional counselor who noted that the MISSD presentation was one of her symposium highlights.

At both conferences, MISSD emphasized the urgent need for better training on medication-induced suicidality and provided practical strategies to help educators and therapists identify akathisia symptoms before it’s too late. MISSD offers all educational resources for free, including public health videos, an accredited e-learning course, podcast series, and brochures. The foundation encourages consumers to use a “medication buddy” when stopping, starting, or changing the dosage or type of medication—someone who can help monitor and report any unusual changes in thinking or behavior.

The Food and Drug Administration (FDA) has Black Box suicide warnings for several commonly prescribed medications used to treat conditions such as acne, seizures, anxiety, smoking cessation, headaches, and depression. This warning is the most stringent caution the FDA can mandate. All Selective Serotonin Reuptake Inhibitors (SSRIs), including Paxil, Prozac, and Zoloft, carry Black Box suicide warnings for children, adolescents, and young adults up to age 25.

"The reality is that medication-induced suicidality can happen to anyone, at any age," said Dolin. "This was evident in numerous clinical drug trials involving healthy volunteers, but suicide risks were strategically downplayed to gain FDA approval. It’s tragic when critical drug risks are minimized because being aware of akathisia causes and symptoms can save lives."

Visit MISSD.co to learn more and access free resources.

Wendy Dolin
MISSD
email us here
Visit us on social media:
Facebook
X
YouTube

What is Akathisia?